AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
13.62
-0.59 (-4.15%)
At close: Mar 6, 2026, 4:00 PM EST
13.53
-0.09 (-0.66%)
After-hours: Mar 6, 2026, 4:02 PM EST
AgomAb Therapeutics NV Employees
AgomAb Therapeutics NV had 58 employees as of December 31, 2024. The number of employees increased by 24 or 70.00% compared to the previous year.
Employees
58
Change (1Y)
24
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,466,924
Market Cap
663.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58 | 24 | 70.00% |
| Dec 31, 2023 | 34 | 33 | 3,300.00% |
| Dec 31, 2019 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 579 |
| Prime Medicine | 214 |
| uniQure | 209 |
| ProKidney | 204 |
| Kura Oncology | 192 |
| Lexicon Pharmaceuticals | 103 |
| Theravance Biopharma | 97 |
AGMB News
- 27 days ago - Agomab Announces Closing of Initial Public Offering - GlobeNewsWire
- 4 weeks ago - U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years - Seeking Alpha
- 4 weeks ago - Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut - Reuters
- 4 weeks ago - Agomab Announces Pricing of Initial Public Offering - GlobeNewsWire
- 5 weeks ago - U.S. IPO Weekly Recap: Trio Of Sizable Listings Underwhelm To Close Out January - Seeking Alpha
- 5 weeks ago - AgomAb Therapeutics NV Readies US IPO On Early Promising Results - Seeking Alpha
- 7 weeks ago - Agomab Therapeutics files for US IPO - Reuters
- 7 weeks ago - AgomAb Therapeutics IPO Registration Document (F-1) - SEC